Complement-Binding Donor-Specific Anti-HLA Antibodies: Biomarker for Immunologic Risk Stratification in Pediatric Kidney Transplantation Recipients

Overview of attention for article published in Transplant International, March 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

twitter: 13 X users
facebook: 1 Facebook page

guideline: 1 clinical guideline source

Readers on

mendeley: 15 Mendeley

So far, Altmetric has seen 24 X posts from 13 X users, with an upper bound of 22,306 followers.

RT @VakaKristin: At Stanford, we have been using complement binding DSAs for risk stratification for over a decade and routinely screen den…

RT @ASPNeph: Complement-Binding Donor-Specific Anti-HLA Antibodies: Biomarker for Immunologic Risk Stratification in Pediatric Kidney #Tran…

RT @VakaKristin: At Stanford, we have been using complement binding DSAs for risk stratification for over a decade and routinely screen den…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 20 additional X posts.